Harri Vainio

1.1k total citations
10 papers, 851 citations indexed

About

Harri Vainio is a scholar working on Molecular Biology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Harri Vainio has authored 10 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Harri Vainio's work include Pharmacogenetics and Drug Metabolism (3 papers), Cancer therapeutics and mechanisms (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Harri Vainio is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Cancer therapeutics and mechanisms (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Harri Vainio collaborates with scholars based in Finland, France and Singapore. Harri Vainio's co-authors include Ari Hirvonen, Gareth Morgan, Taik Koo Yun, Hai Rim Shin, Kirsti Husgafvel‐Pursiainen, Eivor Elovaara, Sisko Anttila, Antti Karjalainen, Sisko Anttila and Tamie Nakajima and has published in prestigious journals such as International Journal of Cancer, Carcinogenesis and Cancer Causes & Control.

In The Last Decade

Harri Vainio

10 papers receiving 807 citations

Peers

Harri Vainio
A. Hirvonen Finland
Yves Barra France
J. Schuppler Germany
J G Liehr United States
Anthony J. Galati United States
Glenda J. Moser United States
A. Hirvonen Finland
Harri Vainio
Citations per year, relative to Harri Vainio Harri Vainio (= 1×) peers A. Hirvonen

Countries citing papers authored by Harri Vainio

Since Specialization
Citations

This map shows the geographic impact of Harri Vainio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harri Vainio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harri Vainio more than expected).

Fields of papers citing papers by Harri Vainio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harri Vainio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harri Vainio. The network helps show where Harri Vainio may publish in the future.

Co-authorship network of co-authors of Harri Vainio

This figure shows the co-authorship network connecting the top 25 collaborators of Harri Vainio. A scholar is included among the top collaborators of Harri Vainio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harri Vainio. Harri Vainio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vainio, Harri. (2001). Is COX-2 inhibition a panacea for cancer prevention?. International Journal of Cancer. 94(5). 613–614. 37 indexed citations
2.
Piirilä, Päivi, Harriet Wikman, Ritva Luukkonen, et al.. (2001). Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure.. Pharmacogenetics. 11(5). 437–445. 85 indexed citations
3.
Shin, Hai Rim, et al.. (2000). The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes & Control. 11(6). 565–576. 184 indexed citations
4.
Sioris, Thanos, Kirsti Husgafvel‐Pursiainen, Antti Karjalainen, et al.. (2000). Survival in operable non-small-cell lung cancer: Role of p53 mutations, tobacco smoking and asbestos exposure. International Journal of Cancer. 86(4). 590–594. 31 indexed citations
5.
Anttila, Sisko, Eivor Elovaara, Antti Karjalainen, et al.. (2000). An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes. Pharmacogenetics. 10(8). 741–751. 33 indexed citations
6.
Husgafvel‐Pursiainen, Kirsti, Maaret Ridanpää, Sisko Anttila, & Harri Vainio. (1995). p53 and ras Gene Mutations in Lung Cancer: Implications for Smoking and Occupational Exposures. Journal of Occupational and Environmental Medicine. 37(1). 69–76. 43 indexed citations
7.
Nakajima, Tamie, Eivor Elovaara, Sisko Anttila, et al.. (1995). Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis. 16(4). 707–711. 152 indexed citations
8.
Hirvonen, Ari, et al.. (1993). PCR-based CYP2D6 genotyping for Finnish lung cancer patients. Pharmacogenetics. 3(1). 19–27. 44 indexed citations
9.
Hirvonen, Ari, et al.. (1993). The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis. 14(7). 1479–1481. 210 indexed citations
10.
Hirvonen, A., Kirsti Husgafvel‐Pursiainen, Sisko Anttila, et al.. (1992). Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer. Pharmacogenetics. 2(6). 259–263. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026